glp 1 agonist indications for GLP-1/GIP RA Summary Sheet and Beyond! Market Overview: GLP-1 Agonists and
Description
M.et al (2020)
Coverage is highly plan-specific
Clinical trials show semaglutide reduces body weight by 10-15% over six months when combined with lifestyle changes
This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio
Irfan, H
